CareFusion Stock Hits New 52-Week High (CFN)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- CareFusion (NYSE: CFN) hit a new 52-week high Wednesday as it is currently trading at $28.75, above its previous 52-week high of $28.73 with 662,468 shares traded as of 3:31 p.m. ET. Average volume has been 1.9 million shares over the past 30 days.

CareFusion has a market cap of $6.28 billion and is part of the health care sector and health services industry. Shares are up 12.5% year to date as of the close of trading on Tuesday.

CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. The company has a P/E ratio of 17.2, below the average health services industry P/E ratio of 21.1 and below the S&P 500 P/E ratio of 17.7.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

TheStreet Ratings rates CareFusion as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share and compelling growth in net income. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. You can view the full CareFusion Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Jim Cramer: The S&P 500 Isn’t as Passive as You Might Think

Jim Cramer's 'Mad Money' Recap: This Is One Stupid Market

3 Stocks Reiterated As A Buy: CFN, UTX, WHR

Insider Trading Alert - CFN, VSR And CAVM Traded By Insiders

Jim Cramer on the Stock Market: Spinoffs Are in Vogue